<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="human CoV have emerged in the past 20 years with" exact="severe acute respiratory syndrome" post="CoV (SARS-CoV) in 2002, Middle East respiratory syndrome CoV"/>
 <result pre="25,000 deaths in 199 countries. Like SARS- and MERS-CoV, the" exact="respiratory disease" post="caused by SARS-CoV-2 can progress to acute lung injury"/>
 <result pre="can progress to acute lung injury (ALI), an end stage" exact="lung disease" post="with limited treatment options and very poor prognoses( 3"/>
 <result pre="to humans. A novel group 1 CoV called swine acute" exact="diarrhea" post="syndrome CoV (SADS-CoV) recently emerged from bats causing the"/>
 <result pre="unrelated RNA viruses including influenza, Ebola, CoV, and Venezuelan equine" exact="encephalitis" post="virus (VEEV)( 13 - 16 ). For VEEV, the"/>
 <result pre="RdRp residues F480L and V557L in a model coronavirus mouse" exact="hepatitis" post="virus (MHV) and in SARS-CoV, resulting in a 5-fold"/>
 <result pre="have demonstrated a high genetic barrier to NHC for VEEV," exact="influenza" post="and CoV ( 14 - 16 ), the lack"/>
 <result pre="depicts percent amino acid identity (% A.A. similarity) against mouse" exact="hepatitis" post="virus (MHV), SARS-CoV, or MERS-CoV. (B) The variation encompassed"/>
 <result pre="RNA of RSV ( 24 ), VEEV ( 14 )," exact="influenza" post="( 24 ), and our previous study used RNA"/>
 <result pre="is broadly active against multiple genetically distinct viruses including VEE," exact="influenza" post="A and B, Ebola, and Chikungunya viruses ( 13"/>
 <result pre="is compressed (e.g., 24-48 hours). As with oseltamivir treatment for" exact="influenza" post="which fails to provide a protective effect if administered"/>
 <result pre="to U, U to C) consistent with those reported after" exact="influenza" post="and VEE infections ( 14 , 15 ). Under"/>
 <result pre=", Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi Arabia . N. Engl. J. Med. 367,"/>
 <result pre="R. , Plemper R. K. , Characterization of orally efficacious" exact="influenza" post="drug with high resistance barrier in ferrets and human"/>
 <result pre="Baric R. S. , A mouse model for MERS coronavirus-induced" exact="acute respiratory distress syndrome" post=". Nat. Microbiol. 2, 16226 ( 2016). 10.1038/nmicrobiol.2016.226 27892925"/>
 <result pre="Y. , Risk factors for severe illness with 2009 pandemic" exact="influenza" post="A (H1N1) virus infection in China . Clin. Infect."/>
 <result pre="Shi, Discovery of a novel coronavirus associated with the recent" exact="pneumonia" post="outbreak in humans and its potential bat origin. bioRxiv,"/>
 <result pre="vaccination strategies that protect aged mice from lethal challenge from" exact="influenza" post="virus and heterologous severe acute respiratory syndrome coronavirus ."/>
 <result pre="aged mice from lethal challenge from influenza virus and heterologous" exact="severe acute respiratory syndrome" post="coronavirus . J. Virol. 85, 217– 230 ( 2011)."/>
 <result pre="influences the infectious dose of MERS-CoV necessary to achieve severe" exact="respiratory disease" post=". Virology 517, 98– 107 ( 2018). 10.1016/j.virol.2017.12.006 29277291"/>
 <result pre=", Systematic assembly of a full-length infectious cDNA of mouse" exact="hepatitis" post="virus strain A59 . J. Virol. 76, 11065– 11078"/>
 <result pre="Serial histopathological examination of the lungs of mice infected with" exact="influenza" post="A virus PR8 strain . PLOS ONE 6, e21207"/>
</results>
